Surgery Center Deals Are Heating Up

In the middle of 2025, ambulatory surgery centers (ASCs) are once again in the investment spotlight—and not just for their strong returns. Thanks to CMS reimbursement updates, consolidation trends, and changing patient preferences, ASCs are proving to be a strategic play for both operators and investors.

Procedures are increasingly shifting from inpatient to outpatient settings. That means more volume—and more revenue—is flowing into these lower-cost, physician-led facilities. Meanwhile, major health systems and private equity firms continue to scale their ASC platforms through joint ventures and roll-ups, boosting deal activity nationwide.

But beneath the surface, the numbers tell a deeper story. Market fundamentals like certificate of need (CON) regulations, surgical case mix, and physician alignment are playing a huge role in real estate strategy and valuation. Knowing how to interpret those metrics is key when assessing an acquisition or disposition.

At Lovelady Perspective, we help healthcare investors, developers, and brokers navigate today’s ASC landscape with market intelligence rooted in what matters most—operations, regulation, and financial performance. If you or your clients are active in this space, we’d love to be a resource.

📅 Book a time to connect: https://calendly.com/contact-loveladyperspective

📬 Subscribe to the newsletter: https://www.loveladyperspective.com/contact